Lanthanum pharmacokinetics: Are rat data misleading?

被引：10

作者：

D'Haese, PC ^{[1
]}

Behets, GJ ^{[1
]}

De Broe, ME ^{[1
]}

Damment, SJP ^{[1
]}

机构：

[1] Univ Antwerp, Fac Med, B-2610 Antwerp, Belgium

来源：

KIDNEY INTERNATIONAL | 2005年 / 68卷 / 06期

关键词：

D O I：

10.1111/j.1523-1755.2005.00583_3.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2907 / 2908

页数：2

共 5 条

[1] Lanthanum carbonate: a new phosphate binder [J].

Behets, GJ ;

Verberckmoes, SC ;

D'Haese, PC ;

De Broe, ME .

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2004, 13 (04) :403-409

[2] Evaluation of the potential genotoxicity of the phosphate binder lanthanum carbonate [J].

Damment, SJP ;

Beevers, C ;

Gatehouse, DG .

MUTAGENESIS, 2005, 20 (01) :29-37

[3]

Damment SJP, 2003, J AM SOC NEPHROL, V14, p204A

[4] Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration [J].

Lacour, B ;

Lucas, A ;

Auchère, D ;

Ruellan, N ;

Patey, NMD ;

Drüeke, TB .

KIDNEY INTERNATIONAL, 2005, 67 (03) :1062-1069

[5] Sevelamer, a phosphate-binding polymer, is a non-absorbed compound [J].

Plone, MA ;

Petersen, JS ;

Rosenbaum, DP ;

Burke, SK .

CLINICAL PHARMACOKINETICS, 2002, 41 (07) :517-523

← 1 →